PMGC Holdings Inc
ELAB2.220USD
-0.690-23.71%
Close 04/24, 16:00（ET）Quotes delayed by 15 min
974.55KMarket Cap
LossP/E TTM
More Details of PMGC Holdings Inc Company
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
Company Info
Company codeELAB
Company namePMGC Holdings Inc
IPO dateNov 21, 2023
Founded at2024
CEOMr. Graydon Bensler
Number of employees2
Security typeOrdinary Share
Fiscal year-endNov 21
Address120 Newport Center Drive
CityNEWPORT BEACH
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92660
Phone18667944940
Websitehttps://pmgcholdings.com/
Company codeELAB
IPO dateNov 21, 2023
Founded at2024
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Graydon Bensler
Mr. Graydon Bensler
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
602.00
--
Mr. Jeffrey Owen (Jeff) Parry
Mr. Jeffrey Owen (Jeff) Parry
Independent Director
Independent Director
29.00
-3.33%
Ms. Juliana L. (Julie) Daley, CPA
Ms. Juliana L. (Julie) Daley, CPA
Independent Director
Independent Director
--
--
Mr. George Kovalyov, CPA
Mr. George Kovalyov, CPA
Independent Director
Independent Director
--
--
Mr. Braeden Lichti
Mr. Braeden Lichti
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Jordan R. Plews, Ph.D.
Dr. Jordan R. Plews, Ph.D.
President
President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Graydon Bensler
Mr. Graydon Bensler
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
602.00
--
Mr. Jeffrey Owen (Jeff) Parry
Mr. Jeffrey Owen (Jeff) Parry
Independent Director
Independent Director
29.00
-3.33%
Ms. Juliana L. (Julie) Daley, CPA
Ms. Juliana L. (Julie) Daley, CPA
Independent Director
Independent Director
--
--
Mr. George Kovalyov, CPA
Mr. George Kovalyov, CPA
Independent Director
Independent Director
--
--
Mr. Braeden Lichti
Mr. Braeden Lichti
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Jordan R. Plews, Ph.D.
Dr. Jordan R. Plews, Ph.D.
President
President
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Enfinity
369.01K
69.96%
Empower
154.68K
29.33%
Scalp & hair cleanser
3.78K
0.72%
White label distributor
0.00
0.00%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Enfinity
369.01K
69.96%
Empower
154.68K
29.33%
Scalp & hair cleanser
3.78K
0.72%
White label distributor
0.00
0.00%
Shareholder
Update time: Wed, Apr 9
Update time: Wed, Apr 9
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Virtu Americas LLC
0.51%
JP Bio Consulting LLC
0.29%
BWL Investments Ltd
0.19%
UBS Financial Services, Inc.
0.18%
L1 Capital Global Opportunities Master Fund Ltd.
0.11%
Other
98.71%
Shareholder Statistics
Shareholder
Proportion
Virtu Americas LLC
0.51%
JP Bio Consulting LLC
0.29%
BWL Investments Ltd
0.19%
UBS Financial Services, Inc.
0.18%
L1 Capital Global Opportunities Master Fund Ltd.
0.11%
Other
98.71%
Type
Shareholder
Proportion
Corporation
0.78%
Research Firm
0.56%
Investment Advisor
0.18%
Individual Investor
0.17%
Other
98.31%
Institutional Shareholding
Update time: Sat, Feb 22
Update time: Sat, Feb 22
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
27
83.35K
11.79%
+70.28K
2024Q4
26
118.11K
17.74%
+41.20K
2024Q3
26
100.72K
60.61%
+43.52K
2024Q2
19
58.15K
61.74%
-1.35M
2024Q1
17
53.01K
61.18%
-1.35M
2023Q4
15
1.42M
52.27%
+1.38M
2023Q3
2
21.85K
25.21%
+21.85K
2023Q2
2
21.85K
25.21%
+21.85K
2023Q1
2
21.85K
25.21%
+21.85K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Virtu Americas LLC
3.59K
0.51%
+3.59K
--
Dec 31, 2024
JP Bio Consulting LLC
2.04K
0.29%
-6.00
-0.29%
Nov 21, 2024
BWL Investments Ltd
1.36K
0.19%
-591.00
-30.26%
Mar 10, 2025
UBS Financial Services, Inc.
1.31K
0.18%
+1.31K
--
Dec 31, 2024
L1 Capital Global Opportunities Master Fund Ltd.
810.00
0.11%
+810.00
--
Sep 24, 2024
MOA Life Plus Co,Ltd.
679.00
0.1%
+679.00
--
May 07, 2024
GB Capital Ltd
602.00
0.09%
+1.00
+0.17%
Mar 10, 2025
Lichti (Braeden William Sinclair)
1.18K
0.17%
+592.00
+100.17%
Mar 10, 2025
BofA Global Research (US)
354.00
0.05%
+354.00
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Nov 22, 2024
Merger
200<1
Nov 22, 2024
Merger
200<1
Date
Type
Ratio
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Mar 06, 2025
Merger
7<1
Nov 22, 2024
Merger
200<1
Nov 22, 2024
Merger
200<1
Nov 22, 2024
Merger
200<1
Nov 22, 2024
Merger
200<1